Polyp Genetics

Abstract

The genetic events involved in the transformation of normal colonic epithelium to neoplastic polyps to invasive carcinoma, as initially proposed by Fearon and Vogelstein, form the foundation of our understanding of colorectal cancer. The identification of the polyp as the precursor lesion to colorectal cancer is the basis of many of our current practices for screening, surveillance, and prevention. The last three decades have seen a veritable explosion in our understanding of the molecular events involved in the pathogenesis of colorectal cancer. It is now clear that there are multiple genetic pathways in the polyp to carcinoma sequence. Some polyps previously thought to be nonneoplastic have now been shown to have malignant potential. Finally, increased understanding of the sequence of genetic events has led to the development of targeted therapeutics. The clinical translation of these scientific advances has made a significant impact on the management of patients with colorectal cancer. Accordingly, it is imperative that all clinicians caring for these patients have an understanding of the genetics of colorectal polyps and cancer. In this article, we review the etiology and genetic pathways to carcinoma associated with a range of polyps of the colon and rectum.

Keywords

polyps - genetics - colorectal - neoplasm

• References

• 1 Vogelstein B, Fearon ER, Hamilton SR , et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319 (9) 525-532
• 2 Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011; 6: 479-507
• 3 Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383 (9927) 1490-1502
• 4 Bosman F, Yan P. Molecular pathology of colorectal cancer. Pol J Pathol 2014; 65 (4) 257-266
• 5 Shroff J, Thosani N, Batra S, Singh H, Guha S. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis. World J Gastroenterol 2014; 20 (48) 18466-18476
• 6 Lin OS, Kozarek RA, Cha JM. Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies. Intest Res 2014; 12 (4) 268-274
• 7 Hewett DG, Rex DK. The big picture: does colonoscopy work?. Gastrointest Endosc Clin N Am 2015; 25 (2) 403-413
• 8 Atkin WS, Edwards R, Kralj-Hans I , et al; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375 (9726) 1624-1633
• 9 Schoen RE, Pinsky PF, Weissfeld JL , et al; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366 (25) 2345-2357
• 10 Segnan N, Armaroli P, Bonelli L , et al; SCORE Working Group. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial—SCORE. J Natl Cancer Inst 2011; 103 (17) 1310-1322
• 11 Winawer SJ, Zauber AG, Ho MN , et al; The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329 (27) 1977-1981
• 12 Nishihara R, Wu K, Lochhead P , et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013; 369 (12) 1095-1105
• 13 Zauber AG, Winawer SJ, O'Brien MJ , et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366 (8) 687-696
• 14 Giacosa A, Frascio F, Munizzi F. Epidemiology of colorectal polyps. Tech Coloproctol 2004; 8 (Suppl. 02) s243-s247
• 15 Heitman SJ, Ronksley PE, Hilsden RJ, Manns BJ, Rostom A, Hemmelgarn BR. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7 (12) 1272-1278
• 16 Rex DK, Lehman GA, Ulbright TM , et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993; 88 (6) 825-831
• 17 Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61 (5) 759-767
• 18 Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011; 8 (12) 686-700
• 19 Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87 (2) 159-170
• 20 Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst 2009; 101 (19) 1308-1324
• 21 Jean GW, Shah SR. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer. Pharmacotherapy 2008; 28 (6) 742-754
• 22 Jiang Y, Kimchi ET, Staveley-O'Carroll KF, Cheng H, Ajani JA. Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer. Cancer 2009; 115 (16) 3609-3617
• 23 Ahnen DJ. The American College of Gastroenterology Emily Couric Lecture—the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived?. Am J Gastroenterol 2011; 106 (2) 190-198
• 24 Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138 (6) 2073-2087.e3
• 25 Rotondano G, Bianco MA, Cipolletta L, Marmo R. Serrated LESions of the COlorectum (SELCO) investigators Prevalence and characteristics of serrated lesions of the colorectum in Italy: A multicentre prospective cohort study. Dig Liver Dis 2015; 47 (6) 512-517
• 26 Qazi TM, O'Brien MJ, Farraye FA, Gould RW, Chen CA, Schroy III PC. Epidemiology of goblet cell and microvesicular hyperplastic polyps. Am J Gastroenterol 2014; 109 (12) 1922-1932
• 27 Kim HY, Kim SM, Seo JH, Park EH, Kim N, Lee DH. Age-specific prevalence of serrated lesions and their subtypes by screening colonoscopy: a retrospective study. BMC Gastroenterol 2014; 14: 82-88
• 28 Szylberg Ł, Janiczek M, Popiel A, Marszałek A. Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract 2015; 2015: 573814
• 29 Yang HM, Mitchell JM, Sepulveda JL, Sepulveda AR. Molecular and histologic considerations in the assessment of serrated polyps. Arch Pathol Lab Med 2015; 139 (6) 730-741
• 30 Wiland IV HO, Shadrach B, Allende D , et al. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum. Am J Surg Pathol 2014; 38 (9) 1290-1297
• 31 Bettington ML, Chetty R. Traditional serrated adenoma: an update. Hum Pathol 2015; 46 (7) 933-938
• 32 Kalady MF. Sessile serrated polyps: an important route to colorectal cancer. J Natl Compr Canc Netw 2013; 11 (12) 1585-1594
• 33 Vasen HFA, Tomlinson I, Castells A. Clinical management of hereditary colorectal cancer syndromes. Nat Rev Gastroenterol Hepatol 2015; 12 (2) 88-97
• 34 Adolph VR, Bernabe K. Polyps in children. Clin Colon Rectal Surg 2008; 21 (4) 280-285
• 35 Cichy W, Klincewicz B, Plawski A. Juvenile polyposis syndrome. Arch Med Sci 2014; 10 (3) 570-577
• 36 van Hattem WA, Langeveld D, de Leng WW , et al. Histologic variations in juvenile polyp phenotype correlate with genetic defect underlying juvenile polyposis. Am J Surg Pathol 2011; 35 (4) 530-536
• 37 Ricci MT, Salemme M, Villanacci V, Varesco L. The genetics of inherited predispositions to colorectal polyps: a quick guide for clinicians. Colorectal Dis 2015; 17 (Suppl. 01) 3-9
• 38 Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70 (4) 829-844
• 39 Song MS, Carracedo A, Salmena L , et al. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 2011; 144 (2) 187-199